DiaMedica Therapeutics Inc. (DMAC)
Across 22 earnings reports since May 05, 2021, DiaMedica Therapeutics Inc. (DMAC) has a clear post-earnings pattern. It moves ±5.51% on average after reporting and finishes higher 40.9% of the time. Its largest post-earnings gain was +14.94% (Aug 12, 2025) and its largest decline was -14.1% (Nov 12, 2025). The next earnings report is predicted for 2026-11-12 (estimated).
Earnings reactions
How DMAC moved on each past earnings report.
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±5.51%
Positive %
40.9%
Negative %
59.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 10, 2026 | ☽ POST | +2.86% | open_in_new |
| May 06, 2026 | ☽ POST | -0.31% | open_in_new |
| Mar 31, 2026 | ☽ POST | -5.17% | open_in_new |
| Nov 12, 2025 | ☽ POST | -14.1% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±5.51%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260812 | open_in_new SEC.gov |
| S-8 | 20260811 | open_in_new SEC.gov |
| 10-Q | 20260810 | open_in_new SEC.gov |
| 8-K | 20260810 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
Frequently asked about DMAC earnings
When does DiaMedica Therapeutics Inc. report earnings next? expand_more
DiaMedica Therapeutics Inc. (DMAC)'s next earnings date is estimated for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DMAC stock move after earnings? expand_more
Over 22 reports, DMAC has moved an average of ±5.51% the session after earnings, closing higher 40.9% of the time.
What was DMAC's biggest post-earnings move? expand_more
DMAC's largest post-earnings gain on record was +14.94% on Aug 12, 2025, and its largest decline was -14.1% on Nov 12, 2025.
Where can I find DiaMedica Therapeutics Inc.'s SEC filings? expand_more
All of DiaMedica Therapeutics Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right